The five-year survival rate of stage IIB cervical cancer after treatment is about 50% to 60%, which should be analyzed with the patient’s condition. Cervical cancer is a common malignant tumor of female reproductive system. According to the staging of International Federation of Gynecology and Obstetrics (FIGO), stage IIB represents the situation that the tumor invades the parietal of the uterus but has not yet invaded the pelvic wall. This period belongs to the middle and early stage, and can be treated with surgical resection, radiotherapy and chemotherapy according to the patient’s condition. After active treatment, stage IIB cervical cancer can obtain a five-year survival rate of about 50% to 60%, and the overall prognosis is good. Attention should be paid to regular postoperative checkups as prescribed by doctors, maintaining good living habits in daily life and proper exercise, which are beneficial to prolonging the survival time.